AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 14 analysts
Fundamentals
Fundamentals institutional score is 92 using growth durability 92.4.
Valuation
Valuation institutional score is 28 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 77 using mean target upside 12.9%; dispersion penalty 9.1; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 74 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 2 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. fundamentals and analyst consensus provide support, while valuation and market sentiment remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 82.6% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +2.17). Confidence: 70%.
Live forward EPS implies next-12-month EPS of ₹25.37. Applying the stock's normalized valuation corridor produces a fair range of ₹302.92 to ₹508.41, with base value near ₹366.09 (-10.1% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹25.37
Forward P/E
16.1x
Base Fair Value
₹366.09
Fair Range
₹302.92 - ₹508.41
Upside To Base
-10.1%
Estimate Source
Live forward EPS
Growth Estimate
+39.1%
5Y Average
2.77
Current
3.10
Overvalued
3.18
Undervalued
2.35
5Y Average
13.29
Current
26.35
Overvalued
20.04
Undervalued
11.94
5Y Average
1.64
Current
3.25
Overvalued
1.88
Undervalued
1.39
Peers & Comparison
Sector: Financials · Theme: Diversified Financials
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
DR. REDDY S LABORATORIES DRREDDYPharmaceuticals | -5.6% | 10.0% | 30.7x Fair | -9% vs avg | -5.0% |
HERO MOTOCORP LIMITED HEROMOTOCOTwo Wheelers | +34.9% | 10.7% | 21.6x Undervalued | -36% vs avg | +26.2% |
BSE LIMITED BSEStock Exchanges & Ratings | +64.0% | 48.9% | 52.5x Premium | +55% vs avg | +51.8% |
HINDALCO INDUSTRIES LTD HINDALCOMetals - Aluminium | +32.1% | 5.5% | 14.2x Undervalued | -58% vs avg | +58.0% |
EICHER MOTORS LTD EICHERMOTTrucks & Buses | +31.5% | 23.2% | 38.1x Fair | +12% vs avg | +41.0% |
HCL TECHNOLOGIES LTD HCLTECHIT Services & Consulting | +3.0% | 13.0% | 21.3x Undervalued | -37% vs avg | -9.5% |
BAJAJ AUTO LIMITED BAJAJ-AUTOTwo Wheelers | +64.0% | 16.3% | 27.9x Undervalued | -18% vs avg | +42.5% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 65.0x Premium | +92% vs avg | +23.2% |
ADITYA BIRLA CAPITAL LTD. trades at a discount (26.4x vs peer avg 33.9x), suggesting potential undervaluation relative to the Diversified Financials cohort. Peers include DR. REDDY S LABORATORIES, HERO MOTOCORP LIMITED, BSE LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹4.99K CrJun 2026Latest net profit
₹893 CrJun 2026Free cash flow
₹-24.13K CrMar 2026Net Profit
₹893 CrProfit conversionPerformance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue + | 9 | 134 | 48 | 4,139 | 61 | 4,158 | 3,792 | 3,853 | 4,010 | 4,507 | 4,384 | 4,572 | 4,990 |
| Interest | 0 | 0 | 0 | 1,804 | 0 | 1,966 | 2,042 | 2,079 | 2,173 | 2,208 | 2,322 | 2,409 | 2,645 |
| Expenses + | 9 | 13 | 15 | 894 | 14 | 858 | 908 | 885 | 926 | 1,052 | 1,075 | 1,094 | 1,142 |
| Financing Profit | 1 | 121 | 34 | 1,440 | 47 | 1,334 | 842 | 889 | 912 | 1,247 | 987 | 1,068 | 1,203 |
| Financing Margin % | 5% | 90% | 70% | 35% | 77% | 32% | 22% | 23% | 23% | 28% | 23% | 23% | 24% |
| Other Income + | 0 | 0 | 0 | 27 | 0 | 43 | 16 | 26 | 31 | 17 | 40 | 12 | 11 |
| Depreciation | 0 | 0 | 0 | 33 | 0 | 34 | 34 | 36 | 35 | 37 | 37 | 37 | 37 |
| Profit before tax | 1 | 121 | 34 | 1,434 | 47 | 1,343 | 825 | 879 | 908 | 1,227 | 990 | 1,043 | 1,177 |
| Tax % | 25% | 25% | 24% | 18% | 19% | 23% | 26% | 26% | 26% | 25% | 25% | 26% | 24% |
| Net Profit + | 1 | 91 | 26 | 1,182 | 38 | 1,032 | 613 | 654 | 676 | 916 | 740 | 777 | 893 |
| EPS in Rs | 0.00 | 0.35 | 0.10 | 4.55 | 0.14 | 3.96 | 2.35 | 2.51 | 2.59 | 3.51 | 2.83 | 2.97 | 3.27 |
| Gross NPA % | 2.51% | 2.50% | 2.27% | 2.24% | 2.27% | 1.68% | 1.51% | 1.33% | 1.30% | ||||
| Net NPA % | 1.27% | 1.36% | 1.25% | 1.24% | 1.35% | 0.95% | 0.85% | 0.70% | 0.68% | ||||
| Raw PDF | |||||||||||||
| YOY Sales Growth % | 20.59% | 44.27% | 507.92% | 3,669.05% | 544.22% | 2,999.50% | 7,746.47% | -6.90% | 6,500.92% | 8.41% | 15.59% | 18.65% | 24.44% |
| Employee Cost % | 74.44% | 5.40% | 15.97% | 6.87% | 11.47% | 6.70% | 7.77% | 7.10% | 7.38% | 7.11% | 8.19% | 7.98% | 8.64% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -11.84 | 0.30 | 0.00 |
| Other income normal | 0.39 | 0.25 | 0.26 | 26.61 | 0.26 | 43.21 | 16.47 | 25.54 | 31.46 | 16.85 | 52.15 | 11.58 | 10.58 |
| Exceptional items AT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9 | 0 | 0 |
| Profit excl Excep | 1 | 91 | 26 | 1,182 | 38 | 1,032 | 613 | 654 | 676 | 916 | 749 | 777 | 893 |
| Profit for PE | 1 | 91 | 26 | 1,182 | 38 | 1,032 | 613 | 654 | 676 | 916 | 749 | 777 | 893 |
| Profit for EPS | 1 | 91 | 26 | 1,182 | 38 | 1,032 | 613 | 654 | 676 | 916 | 740 | 777 | 893 |
| YOY Profit Growth % | -70% | 43% | 3,109% | 1,437% | 7,152% | 1,033% | 2,298% | -45% | 1,692% | -11% | 22% | 19% | 32% |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS